Challenges in the Diagnosis of Urothelial Carcinoma Variants: Can Emerging Molecular Data Complement Pathology Review?

被引:12
|
作者
Solomon, James P.
Lowenthal, Brett M.
Kader, A. Karim
Parsons, J. Kellogg
Flaig, Thomas W.
Siefker-Radtke, Arlene O.
Dyrskjot, Lars
Hansel, Donna E.
机构
[1] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA
[2] Univ Calif San Diego, Dept Urol, San Diego, CA 92103 USA
[3] Univ Colorado, Sch Med, Div Med Oncol, Aurora, CO USA
[4] UTMD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX USA
[5] Aarhus Univ Hosp, Dept Mol Med, Aarhus, Denmark
关键词
TRANSITIONAL-CELL-CARCINOMA; INVASIVE MICROPAPILLARY CARCINOMA; LYMPHOEPITHELIOMA-LIKE CARCINOMA; MATCHED COHORT ANALYSIS; URINARY-BLADDER; RADICAL CYSTECTOMY; CLINICOPATHOLOGICAL ANALYSIS; NEOADJUVANT CHEMOTHERAPY; CLINICAL-OUTCOMES; LUMINAL SUBTYPES;
D O I
10.1016/j.urology.2016.10.014
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Urothelial carcinoma can exhibit a wide variety of histopathologic phenotypes or variant morphologies, classifications of which have recently been revised in the 2016 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs. Many of these variants not only present diagnostic challenges, but also have clinical implications that affect patient prognosis and treatment strategies. This review will discuss these variant morphologies and their relationship to current understanding of the underlying biology of urothelial carcinoma and molecular classification paradigms. (C) 2016 Elsevier Inc.
引用
收藏
页码:7 / 16
页数:10
相关论文
共 27 条
  • [1] Histologic Variants of Urothelial Carcinoma: Morphology, Molecular Features and Clinical Implications
    Alderson, Meera
    Grivas, Petros
    Milowsky, Matthew I.
    Wobker, Sara E.
    BLADDER CANCER, 2020, 6 (02) : 107 - 122
  • [2] Molecular pathology of urothelial carcinoma
    Lopez-Beltran, Antonio
    Cimadamore, Alessia
    Montironi, Rodolfo
    Cheng, Liang
    HUMAN PATHOLOGY, 2021, 113 : 67 - 83
  • [4] Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma
    Kurtoglu, Metin
    Davarpanah, Nicole N.
    Qin, Rui
    Powles, Thomas
    Rosenberg, Jonathan E.
    Apolo, Andrea B.
    CLINICAL GENITOURINARY CANCER, 2015, 13 (05) : 410 - 420
  • [5] Overview of histologic variants of urothelial carcinoma: current trends and narrative review on treatment outcomes
    Ogbue, Olisaemeka
    Haddad, Abdo
    Almassi, Nima
    Lapinski, James
    Daw, Hamed
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2022, 11 (06) : 877 - +
  • [6] Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma
    Ikeda, Sadakatsu
    Hansel, Donna E.
    Kurzrock, Razelle
    CANCER TREATMENT REVIEWS, 2015, 41 (08) : 699 - 706
  • [7] Fine-needle aspiration diagnosis of metastatic urothelial carcinoma: A review
    Cantley, R. L.
    Kapur, U.
    Truong, L.
    Cimbaluk, D.
    Barkan, G. A.
    Wojcik, E.
    Gattuso, P.
    DIAGNOSTIC CYTOPATHOLOGY, 2012, 40 (02) : 173 - 178
  • [8] Diagnosis and Management of Urothelial Carcinoma In Situ of the Lower Urinary Tract: A Systematic Review
    Casey, Rowan G.
    Catto, James W. F.
    Cheng, Liang
    Cookson, Michael S.
    Herr, Harry
    Shariat, Sharokh
    Witjes, J. Alfred
    Black, Peter C.
    EUROPEAN UROLOGY, 2015, 67 (05) : 876 - 888
  • [9] Upper urinary tract urothelial carcinoma and its variants: transition from morphology to personalized molecular characterization in diagnosis, prognosis, and therapy
    Cimadamore, Alessia
    Scarpelli, Marina
    Santoni, Matteo
    Cheng, Liang
    Lopez-Beltran, Antonio
    Montironi, Rodolfo
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2018, 18 (12) : 1021 - 1028
  • [10] CA125 for the Diagnosis of Advanced Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis
    Lin, Hsuan-Jen
    Hu, Rouh-Mei
    Chen, Hung-Chih
    Lin, Chung-Chih
    Lee, Chi-Yu
    Chou, Che-Yi
    CANCERS, 2023, 15 (03)